Treatment of brain metastases of lung cancer with high doses of etoposide (VP16-213). Cooperative study from the Groupe Franais Pneumo-Cancérologie.

[1]  P. Postmus,et al.  Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  D. Johnson,et al.  Etoposide-induced hepatic injury: a potential complication of high-dose therapy. , 1983, Cancer treatment reports.

[3]  J. Hainsworth,et al.  High-dose VP-16-213 and autologous bone marrow transplantation for refractory malignancies: a phase I study. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  N. Vogelzang,et al.  VP-16-213 (etoposide): the mandrake root from Issyk-Kul. , 1982, The American journal of medicine.

[5]  B. Issell,et al.  Etoposide (VP-16-213). , 1979, Cancer treatment reviews.